Eterna Therapeutics Inc (ERNA) financials · $6.9M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Eterna Therapeutics Inc (ERNA) $6.9M cap.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Revenue | — | $582.00K | |
| Cost of Revenue | — | $96.00K | |
| Gross Profit | — | $486.00K | |
| Operating Income | −$9.32M | −$15.67M | |
| Net Income | −$14.08M | −$44.54M | |
| EPS (Diluted) | −$2.24 | −$3.26 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $5.83M | $5.27M | |
| Current Assets | $3.13M | $2.35M | |
| Cash & Equivalents | $1.88M | $1.73M | |
| PP&E | $94.00K | $85.00K | |
| Total Liabilities | $3.43M | $3.57M | |
| Current Liabilities | $3.11M | $2.94M | |
| Shareholders' Equity | $2.40M | $1.70M | |
| Retained Earnings | −$245.64M | −$231.54M |
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$7.02M | −$15.84M | |
| CapEx | $37.00K | $369.00K | |
| Investing Cash Flow | −$37.00K | −$365.00K | |
| Financing Cash Flow | $7.21M | $6.26M | |
| Free Cash Flow | −$7.05M | −$16.20M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is ERNA P/E and revenue?
Eterna Therapeutics Inc (ERNA) $6.9M cap.
What is ERNA revenue?
ERNA income-statement cache has no revenue figure yet.
Is ERNA profitable?
Eterna Therapeutics Inc last cached net income is -$14.1M (FY2025).
What are ERNA total assets?
Eterna Therapeutics Inc last cached total assets are $5.83M (FY2025).
What is ERNA free cash flow?
Eterna Therapeutics Inc last cached free cash flow is -$7.05M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.